Search results for: 'Preferred Destination for Clinical Trials'

The study covers the healthcare market which develops and provides products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. The biosimilars market in India is expected to cross $0.9 billion by 2020. The growing prevalence of chronic diseases with an increasing aged population in India and globally, c...

03 Jul 2019  |  Asia Pacific  |  Market Research

Assessment of Automotive Retailing in China, 2018

Engagement of Individual Offline Touchpoints and Omni-channel Interdependence to Transform China’s Automotive Retail Market

Infographics

×

Key Issues Addressed

The automotive retail market in China is likely to undergo a market transformation from experiential service to experience engagement; as well as from a complete sales solution to an intensive sales solution from 2018 to 2025. The automotive retail market is experiencing its maturity and a marketing approach of “everyone is a potential consumer”. I...

In 2020, the Asia-Pacific BPM services market generated a revenue of $121.49 billion; it is forecast to reach $158.39 billion in 2027 at a CAGR of 3.9%. The region continues to be the preferred service delivery hub; India is the preferred IT and BPM services location and the Philippines is the preferred customer experience (CX) outsourcing location...

In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...

This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as we...

With stiff competition in the telecommunications space, along with eroding margins due to the presence of Over-the-Top (OTT) participants providing communication services, operators have been looking for additional revenue streams to boost both their top line and bottom line. Realizing this, Frost & Sullivan has published a study documenting the ac...

This research service analyses the IVD in Korea, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

This research service analyses the IVD in China, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

The IVD market in China presents diversified growth potential for different tiers of participants: domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the high-end market. This research service analyzes the IVD market and provides forecasts and opportunities by underst...